Table 1 General demographics of study participants.
NTM-PD (n = 20) | dNTM (n = 22) | MTB-PD (n = 14) | Oth-PD (n = 32) | HC (n = 25) | |
|---|---|---|---|---|---|
Median of age in years (IQR) | 60 (34–81) | 54 (40–72) | 47 (18–67)* | 62 (38–86)* | 53 (23–70) |
Number of females (%) | 14/20 (70.0%) | 9/22 (40.1%)** | 5/14 (35.7%)** | 13/32 (40.6%)** | 16/25 (64%) |
Number of anti-IFN-γ auAb positive titer (%) | 0/20 (0%) | 22/22 (100%) | 0/14 (0%) | 0/40 (0%) | 0/25 (0%) |
Culture positive organism (%) | M. abscessus complex (8/20, 40%) M. intracellulare (3/20, 15%) M. scrofulaceum (2/20, 10%) M. avium (1/20, 5%) M. malmoense (1/20, 5%) M. simiae (1/20, 5%) M. szulgai (1/20, 5%) Rapidly glowing mycobacteria (1/20, 5%) Unidentified NTM (1/20, 5%) | M. abscessus (15/22, 68.2%) M. intracellulare (4/22, 18.2%) M. kansasii (1/22, 4.5%%) Unidentified NTM (2/22, 9.1%) | M. tuberculosis (14/14, 100%) | K. pneumoniae (11/32, 34.4%) E. coli (10/32, 31.3%) P. aeruginosa (7/32, 21.9%) B. pseudomallei (1/32, 3.1%) E. coli and K. pneumoniae (2/32, 6.3%) K. pneumoniae and P. aeruginosa (1/32, 3.1%) | Not determined |